SKI Market

A+| A| A-|

Indian Indices

Sensex

77,569.39 827.57
( 1.08%)

Global Indices

Nasdaq

52,499.17 129.78
(0.25%)

Dow Jones

7,562.80 59.09
(0.79%)

Hang Seng

68,634.11 890.26
(1.31%)

Nikkei 225

10,498.02 25.57
(0.24%)

Forex

USD-INR

95.15 -0.21
(-0.22%)

EUR-INR

108.73 -0.26
(-0.24%)

GBP-INR

127.27 -0.11
(-0.09%)

JPY-INR

0.59 0.00
(-0.14%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Accel Ltd

Industry : Computers - Software - Medium / Small

BSE Code

ISIN Demat

Book Value()

517494

INE258C01038

7.9524585

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

10.96

72.67

EPS(TTM)

Face Value()

Div & Yield %

1.14

Back

Aarey Drugs & Pharmaceuticals standalone net profit rises 231.91% in the March 2026 quarter

Jun 01,2026

Net profit of Aarey Drugs & Pharmaceuticals rose 231.91% to Rs 1.56 crore in the quarter ended March 2026 as against Rs 0.47 crore during the previous quarter ended March 2025. Sales rose 75.27% to Rs 189.47 crore in the quarter ended March 2026 as against Rs 108.10 crore during the previous quarter ended March 2025.

For the full year,net profit declined 1.24% to Rs 3.97 crore in the year ended March 2026 as against Rs 4.02 crore during the previous year ended March 2025. Sales declined 0.35% to Rs 472.27 crore in the year ended March 2026 as against Rs 473.94 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	189.47	108.10	75	472.27	473.94	0
OPM %	2.29	-3.89	-	1.52	0.61	-
PBDT	2.13	2.04	4	8.26	8.04	3
PBT	1.28	1.63	-21	5.41	6.10	-11
NP	1.56	0.47	232	3.97	4.02	-1

77,569.39 827.57 ( 1.08%)

52,499.17 129.78 (0.25%)

7,562.80 59.09 (0.79%)

68,634.11 890.26 (1.31%)

10,498.02 25.57 (0.24%)

95.15 -0.21 (-0.22%)

108.73 -0.26 (-0.24%)

127.27 -0.11 (-0.09%)

0.59 0.00 (-0.14%)